| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Chief Scientific Officer
1 company
Hongming Chen last filed a Form 4 in October 2021, as Chief Scientific Officer at KALA. Hongming Chen's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Hongming Chen a strong insider score of 84/100, based on 4 past trades. Over a 12-month horizon, all 4 of those trades were profitable, with an average 12-month return of +93.5%.
At the last filing, the largest reported position was 204,515 shares of KALA. The KALA filings lean toward selling, a net 38,500 shares.
Hongming Chen has 14 Form 4 filings on record from July 2017 to October 2021, all as Chief Scientific Officer at Kala Bio (KALA), 2017–2021.
The 17 reported transactions were 5 option exercises, 5 option or other derivative awards, 4 open-market sales and 3 stock awards.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $100K.
The largest open-market sale was 30,500 shares of KALA at an average $1.81 on October 27, 2021, about $55K. Twelve months later KALA was down 93%.
Shares as reported in the last Form 4 for each company; the most recent is from October 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2021 | KALA Kala Bio, Inc. | Chief Scientific Officer | Sell | 30,500 | $1.81 | $55,321.02 | -13.0% | -49.1% | -93.0% | |
| Jun 29, 2021 | KALA Kala Bio, Inc. | Chief Scientific Officer | Sell | 5,548 | $5.56 | $30,846.88 | -2.3% | -45.5% | -94.1% | |
| Jun 28, 2021 | KALA Kala Bio, Inc. | Chief Scientific Officer | Sell | 2,452 | $5.77 | $14,148.04 | -1.0% | -46.6% | -93.9% |